These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12006992)

  • 1. [hEPO transfer and expression by a recombinant adeno-associated virus vector].
    Wu ZJ; Wu XB; Wang H; Lu B; Dong XY; Hou YD
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):176-80. PubMed ID: 12006992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus mediated expression of human erythropoietin in vitro.
    Diao Y; Xu RA; Wang GJ; Zhao XC
    Acta Pharmacol Sin; 2002 Jan; 23(1):55-8. PubMed ID: 11860738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates.
    Zhou S; Murphy JE; Escobedo JA; Dwarki VJ
    Gene Ther; 1998 May; 5(5):665-70. PubMed ID: 9797871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
    Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
    J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders.
    Voutetakis A; Bossis I; Kok MR; Zhang W; Wang J; Cotrim AP; Zheng C; Chiorini JA; Nieman LK; Baum BJ
    J Endocrinol; 2005 Jun; 185(3):363-72. PubMed ID: 15930162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
    Cheng J; Leng X; Peng J
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
    Zhang X; Li CY
    Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.
    McCarty DM; Monahan PE; Samulski RJ
    Gene Ther; 2001 Aug; 8(16):1248-54. PubMed ID: 11509958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
    O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
    J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.
    Beall CJ; Phipps AJ; Mathes LE; Stromberg P; Johnson PR
    Gene Ther; 2000 Mar; 7(6):534-9. PubMed ID: 10757028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys.
    Rudich SM; Zhou S; Srivastava R; Escobedo JA; Perez RV; Manning WC
    J Surg Res; 2000 May; 90(2):102-8. PubMed ID: 10792948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy.
    Hsu PY; Yang YW
    J Gene Med; 2005 Oct; 7(10):1311-21. PubMed ID: 15906397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
    Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
    Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors.
    Braun-Falco M; Doenecke A; Smola H; Hallek M
    Gene Ther; 1999 Mar; 6(3):432-41. PubMed ID: 10435093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping.
    Ni W; Le Guiner C; Gernoux G; Penaud-Budloo M; Moullier P; Snyder RO
    Gene Ther; 2011 Jul; 18(7):709-18. PubMed ID: 21390073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimised helper virus-free production of high-quality adeno-associated virus vectors.
    Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M
    J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gene expression in vivo following transduction by two separate rAAV vectors.
    Rendahl KG; Leff SE; Otten GR; Spratt SK; Bohl D; Van Roey M; Donahue BA; Cohen LK; Mandel RJ; Danos O; Snyder RO
    Nat Biotechnol; 1998 Aug; 16(8):757-61. PubMed ID: 9702775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
    Isayeva T; Ren C; Ponnazhagan S
    Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.